Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Centenial Surgical Suture Ltd

NSE: CSURGSU · BSE: 531380 · Healthcare · 17 announcements

Share price
₹94.25
Market cap
₹34.39 Cr
Revenue (annual)
₹53.84 Cr
Net profit (annual)
₹-2.20 Cr
P/E (TTM)
-23.8×Sector 53.1×
Promoter holding
46.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

23:51 IST BSE
Management Change

Centenial Surgical Suture Management Change

Centenial Surgical Suture Ltd has appointed Ms. Sapna Mhatre as Chief Financial Officer, succeeding Ms. Anuradha Kashikar, who resigned from the position effective August 14, 2026.

20:06 IST BSE
Annual Report

Centenial Surgical Suture Annual Report

Centenial Surgical Suture Ltd has filed its 31st Annual Report for the financial year 2025-2026 as per SEBI (LODR) Regulations.

19:50 IST BSE
Annual General Meeting

Centenial Surgical Suture Annual General Meeting

Centenial Surgical Suture Ltd. has released the notice for its 31st Annual General Meeting for FY 2025-26, which is available to shareholders via its website.

19:15 IST BSE
Annual General Meeting

Centenial Surgical Suture Annual General Meeting

Centenial Surgical Suture Ltd has announced the closure of its share transfer books from September 22 to September 28, 2026, for its 31st AGM.

18:55 IST BSE
Management Change

Centenial Surgical Suture Management Change

Centenial Surgical Suture Ltd has appointed Ms. Sapna Mhatre as the new Chief Financial Officer. Ms. Anuradha Kashikar has resigned from the CFO position effective August 14, 2026.

18:48 IST BSE
Other Announcement

Centenial Surgical Suture Other Announcement

Centenial Surgical Suture Ltd has appointed M/s. Utsav Shah & Associates as the internal auditor for the financial year 2026-2027.

18:20 IST BSE
Board Meeting Outcome

Centenial Surgical Suture Board Meeting Outcome

Centenial Surgical Suture announced Q1 financial results, CFO change, and AGM details following their August 14, 2026 board meeting.